Amanote Research
Register
Sign In
Intraocular Pressure-Lowering Efficacy of Bimatoprost 0.03% and Travoprost 0.004% in Patients With Glaucoma or Ocular Hypertension
British Journal of Ophthalmology
- United Kingdom
doi 10.1136/bjo.2006.094326
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Date
November 1, 2006
Authors
L B Cantor
J Hoop
L Morgan
D WuDunn
Y Catoira
Publisher
BMJ
Related search
Evaluating Intraocular Pressure-Lowering Solutions for the Treatment of Open-Angle Glaucoma: Comparison Between Bimatoprost 0.03% and Bimatoprost 0.01% &Ndash; An Observational Switch Study
Clinical Ophthalmology
Ophthalmology
Efficacy and Safety of Travoprost Alone or in Combination With Other Agents for Glaucoma and Ocular Hypertension: Patient Considerations
Clinical Ophthalmology
Ophthalmology
First Experience With BAK-free Travoprost 0.004% in Topical Glaucoma Medication
Clinical Ophthalmology
Ophthalmology
24-Hour Intraocular Pressure and Ocular Perfusion Pressure in Glaucoma
Survey of Ophthalmology
Ophthalmology
A Randomized Crossover Study Comparing Tafluprost 0.005% With Travoprost 0.004% in Patients With Normal-Tension Glaucoma
Clinical Ophthalmology
Ophthalmology
ICare Pro: Age Dependent Effect of Central Corneal Thickness on Intraocular Pressure in Glaucoma and Ocular Hypertension Patients
Current Eye Research
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Comparing the Predicted Efficacy of One Versus Two Supraciliary Micro‐stents for Lowering Intraocular Pressure in Glaucoma Patients Using an Ocular Computational Fluid Dynamic Model
Acta Ophthalmologica
Medicine
Ophthalmology
Effects of Corneal Thickness on the Intraocular Penetration of Travoprost 0.004%
Eye
Medicine
Arts
Sensory Systems
Ophthalmology
Humanities
Sustainability of Intraocular Pressure Reduction of Travoprost Ophthalmic Solution in Subjects With Normal Tension Glaucoma
Advances in Therapy
Medicine
Pharmacology
